These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 7505985)
21. [Markers for diagnosis, prediction and prognosis of prostate cancer]. Taskén KA; Angelsen A; Svindland A; Eide T; Berge V; Wahlquist R; Karlsen S Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3279-82. PubMed ID: 16327854 [TBL] [Abstract][Full Text] [Related]
22. Relationship between prostate size and percent free prostate-specific antigen in patients with operable prostate cancer. Nativ O; Sabo E; Wald M; Halachmi S; Moskovitz B Isr Med Assoc J; 2000 Dec; 2(12):889-91. PubMed ID: 11344767 [TBL] [Abstract][Full Text] [Related]
23. Decision analyses in consideration of treatment strategies for patients with biochemical failure after curative therapy on clinically localized prostate cancer in the prostate-specific antigen era. Shimizu F; Igarashi A; Fukuda T; Kawachi Y; Minowada S; Ohashi Y; Fujime M Jpn J Clin Oncol; 2007 Oct; 37(10):763-74. PubMed ID: 17956899 [TBL] [Abstract][Full Text] [Related]
24. High PSA. Field L J Tenn Med Assoc; 1993 Mar; 86(3):105-8. PubMed ID: 7680394 [No Abstract] [Full Text] [Related]
25. [Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer]. Meguro N; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T Hinyokika Kiyo; 1998 Sep; 44(9):639-43. PubMed ID: 9805668 [TBL] [Abstract][Full Text] [Related]
26. [Markers of prostatic carcinoma]. Safarík L Cas Lek Cesk; 1998 Aug; 137(17):525-7. PubMed ID: 9787505 [TBL] [Abstract][Full Text] [Related]
27. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening. Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715 [TBL] [Abstract][Full Text] [Related]
28. Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer. Ogawa A; Yoshida A; Kanda T; Sugihara S; Suzuki T; Tamura J; Kobayashi I; Nakazato Y J Med; 2000; 31(1-2):101-10. PubMed ID: 10998759 [TBL] [Abstract][Full Text] [Related]
29. Patient education. PSA: pros and cons. Gattellari M; Ward JE Aust Fam Physician; 2003 Jun; 32(6):429-30. PubMed ID: 12833769 [No Abstract] [Full Text] [Related]
30. We need a better marker for prostate cancer. How about renaming PSA? Vickers AJ; Lilja H Urology; 2012 Feb; 79(2):254-5. PubMed ID: 22196413 [No Abstract] [Full Text] [Related]
31. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Sheridan T; Herawi M; Epstein JI; Illei PB Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190 [TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical staining of precursor forms of prostate-specific antigen (proPSA) in metastatic prostate cancer. Parwani AV; Marlow C; Demarzo AM; Mikolajczyk SD; Rittenhouse HG; Veltri RW; Chan TY Am J Surg Pathol; 2006 Oct; 30(10):1231-6. PubMed ID: 17001152 [TBL] [Abstract][Full Text] [Related]
33. [Prostate-specific antigen]. Eide IA; Angelsen A Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2528-31. PubMed ID: 11070990 [TBL] [Abstract][Full Text] [Related]
34. [Prostate-specific antigen and its related parameters in detecting prostate cancer]. Kuruma H; Egawa S Gan To Kagaku Ryoho; 2003 Jan; 30(1):11-5. PubMed ID: 12557698 [TBL] [Abstract][Full Text] [Related]
35. Free and total human glandular kallikrein 2 in patients with prostate cancer. Väisänen V; Pettersson K; Alanen K; Viitanen T; Nurmi M Urology; 2006 Jul; 68(1):219-25. PubMed ID: 16844459 [TBL] [Abstract][Full Text] [Related]
36. [Should I check the PSA?]. Johansen TE Tidsskr Nor Laegeforen; 1998 Sep; 118(22):3400. PubMed ID: 9800487 [No Abstract] [Full Text] [Related]
37. Update on screening for prostate cancer with prostate-specific antigen. Schmid HP; Riesen W; Prikler L Crit Rev Oncol Hematol; 2004 Apr; 50(1):71-8. PubMed ID: 15094160 [TBL] [Abstract][Full Text] [Related]
38. Are multiple markers the future of prostate cancer diagnostics? Mikolajczyk SD; Song Y; Wong JR; Matson RS; Rittenhouse HG Clin Biochem; 2004 Jul; 37(7):519-28. PubMed ID: 15234233 [TBL] [Abstract][Full Text] [Related]
39. [Advanced prostate cancer with normal serum prostate-specific antigen values]. Komura T; Yamagiwa K; Ogura H; Kohjimoto Y; Ohkawa T; Inagaki T; Ebisuno S; Senzaki A Hinyokika Kiyo; 1998 May; 44(5):303-6. PubMed ID: 9656099 [TBL] [Abstract][Full Text] [Related]
40. Prostate-specific antigen: current status. Lukes M; Urban M; Záleský M; Zachoval R; Herácek J; Zdárský E Folia Biol (Praha); 2001; 47(2):41-9. PubMed ID: 11321246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]